Talis Biomedical Corp Insiders
Talis Biomedical employs about 99 people. The company is managed by 12 executives with a total tenure of roughly 231 years, averaging almost 19.0 years of service per executive, having 8.25 employees per reported executive. Breaking down Talis Biomedical's management performance can provide insight into the firm performance.
| Andrew Lukowiak President President Officer |
Talis |
Talis Biomedical Management Team Effectiveness
The company has return on total asset (ROA) of (0.2959) % which means that it has lost $0.2959 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7048) %, meaning that it created substantial loss on money invested by shareholders. Talis Biomedical's management efficiency ratios could be used to measure how well Talis Biomedical manages its routine affairs as well as how well it operates its assets and liabilities.Talis Biomedical Workforce Comparison
Talis Biomedical Corp is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,924. Talis Biomedical holds roughly 99.0 in number of employees claiming about 5% of equities under Health Care industry.
Talis Biomedical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Talis Biomedical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Talis Biomedical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Talis Biomedical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Talis Biomedical Notable Stakeholders
A Talis Biomedical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Talis Biomedical often face trade-offs trying to please all of them. Talis Biomedical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Talis Biomedical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Andrew Lukowiak | President Officer | Profile | |
| Roger Moody | Chief Officer | Profile | |
| Gillian Green | Company Secretary | Profile | |
| Margaret MS | Controller | Profile | |
| Rustem Ismagilov | CoFounder Director | Profile | |
| Rebecca Markovich | Interim Officer | Profile | |
| Jill Green | Senior Legal | Profile | |
| MBA Moody | Chief Officer | Profile | |
| Robert MBA | CEO Director | Profile | |
| Liang Li | CoFounder Strategy | Profile | |
| Emily Faucette | Senior Relations | Profile | |
| Matthew Pepe | Director Resource | Profile |
Talis Biomedical Workforce Analysis
Traditionally, organizations such as Talis Biomedical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Talis Biomedical within its industry.Talis Biomedical Manpower Efficiency
Return on Talis Biomedical Manpower
| Revenue Per Employee | 4.2K | |
| Revenue Per Executive | 34.3K | |
| Net Loss Per Employee | 626.3K | |
| Net Loss Per Executive | 5.2M | |
| Working Capital Per Employee | 696.1K | |
| Working Capital Per Executive | 5.7M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Talis Pink Sheet
If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |